FDA OKs Risdiplam
A few days ago FDA officially okayed risdiplam (Evrysdi; Genentech) for the treatment of spinal muscular atrophy (SMA) for adults and children not younger than…
Approval
Esketamine Nasal Spray New Indication
Esketamine (Spravato; Janssen) CIII nasal spray is the first FDA-approved antidepressant medication that improves depressive symptoms with the first dose in adults with major depressive…
CBD Seizures Treatment Approved By The FDA
On July 31, The Food and Drug Administration (FDA) has approved seizures treatment containing cannabidiol (CBD) (Epidiolex, Greenwich Biosciences Inc). This is an oral solution…
The FDA Approved The Spinal Cord Treatment
The U.S. Food and Drug Administration (FDA) has approved Uplizna injection for intravenous use for the therapy of neuromyelitis optica spectrum disorder (NMOSD) that affects…
Heart Failure Medication Approved
The FDA has awarded a further implication for dapagliflozin (Farxiga, AstraZeneca Pharmaceuticals), heart failure medication, the first sodium-glucose co-transporter 2 (SGLT2) inhibitor to be allowed…
Tabrecta (lapatinib) Approved By The FDA
The U.S. Food and Drug Administration recommended Tabrecta (lapatinib) – lung cancer medication against non-small cell lung cancer (NSCLC) that has expanded to other parts…
Anti-Schizophrenia Drug Approved by The FDA
FDA has confirmed lumateperone tosylate (Caplyta™, Intra-Cellular Therapies) anti-schizophrenia drug for the therapy of schizophrenia in grown-up sufferers. Lumateperone is an atypical antipsychotic. The precise…
Breast Cancer Medication Approved By The FDA
Nowadays, the U.S. Food and Drug Administration has established Tukysa (tucatinib) in combination with chemotherapy (trastuzumab and capecitabine) for the therapy of grownup sufferers with…
Debilitating and Disfiguring Disease Treatment
Nowadays, the U.S. Food and Drug Administration recommended Koselugo (selumetinib) for the therapy of pediatric sufferers, two years of age and older, with neurofibromatosis type…
FDA Process For COVID-19 Test
FDA has announced Emergency Use Authorization (EUA) for a 5-minute point-of-care COVID-19 test, the virus that produces the novel coronavirus, according to a press statement….